hong york - ( business wire ) pfizer ltd established 2018 that it has became the third medicinal company to be accredited by the association for the accreditation of clinical research protect programming ( aahrpp ) for preserving the protection of human subjects taking part in earliest - phase clinical trials . the aahrpp classification was awarded to pfizer ' s pharmaceutical development units ( crus ) in new haven , ct , flemish , france and singapore , where the company conducts most of its phase i pharmaceutical research . to obtain the accreditation , pfizer participated in a rigorous , 15 - months examination of the clinical research practices at these units .
Pfizer is a pharmaceutical company.